Loading...
XASXAHX
Market cap44mUSD
Jan 08, Last price  
0.39AUD
1D
2.63%
1Q
-17.89%
Jan 2017
-68.80%
IPO
-68.80%
Name

Apiam Animal Health Ltd

Chart & Performance

D1W1MN
XASX:AHX chart
P/E
14.44
P/S
0.35
EPS
0.03
Div Yield, %
1.86%
Shrs. gr., 5y
11.23%
Rev. gr., 5y
12.87%
Revenues
205m
+6.73%
054,097,00097,991,000106,597,000111,720,000118,335,000126,181,000157,057,000191,757,000204,656,000
Net income
5m
+116.56%
-748,00050,0005,027,0003,278,0003,165,0004,171,0005,082,0004,639,0002,277,0004,931,000
CFO
19m
+8.15%
-652,000-1,237,0001,670,0009,217,0004,884,0007,507,00013,689,00015,078,00017,455,00018,878,000
Dividend
Aug 28, 20240.01 AUD/sh
Earnings
Feb 21, 2025

Profile

Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia. The company operates through three segments: Dairy and Mixed, Feedlots, and Pigs. It engages in the provision of veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services. The company offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services. It also provides telemedicine, remote video headgear, health management apps for production animals systems, benchmarking databases, and herd management software. The company offers general animal health products through eCommerce. It provides its services through animal veterinary clinics. The company was founded in 1998 and is based in Bendigo, Australia.
URL
https://www.apiam.com.au/
IPO date
Dec 15, 2015
Employees
950
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
204,656
6.73%
191,757
22.09%
157,057
24.47%
Cost of revenue
158,557
185,598
149,275
Unusual Expense (Income)
NOPBT
46,099
6,159
7,782
NOPBT Margin
22.53%
3.21%
4.95%
Operating Taxes
2,154
995
1,931
Tax Rate
4.67%
16.16%
24.81%
NOPAT
43,945
5,164
5,851
Net income
4,931
116.56%
2,277
-50.92%
4,639
-8.72%
Dividends
(1,322)
(673)
(2,356)
Dividend yield
2.11%
0.74%
2.49%
Proceeds from repurchase of equity
18,109
BB yield
-19.14%
Debt
Debt current
5,913
7,918
6,472
Long-term debt
133,380
114,152
56,918
Deferred revenue
1
24,043
17,753
Other long-term liabilities
1,116
1,049
1,162
Net debt
137,263
118,624
60,274
Cash flow
Cash from operating activities
18,878
17,455
15,078
CAPEX
(4,778)
(8,205)
(4,864)
Cash from investing activities
(10,907)
(40,620)
(32,495)
Cash from financing activities
(9,386)
23,492
18,112
FCF
39,576
(3,394)
972
Balance
Cash
1,757
3,172
2,845
Long term investments
273
274
271
Excess cash
Stockholders' equity
122,029
117,896
108,684
Invested Capital
224,924
216,972
171,377
ROIC
19.89%
2.66%
3.82%
ROCE
20.22%
2.79%
4.45%
EV
Common stock shares outstanding
181,989
177,762
138,142
Price
0.35
-32.35%
0.51
-25.55%
0.69
-28.65%
Market cap
62,786
-30.74%
90,659
-4.19%
94,627
-20.52%
EV
200,054
209,311
155,035
EBITDA
46,099
16,386
16,141
EV/EBITDA
4.34
12.77
9.61
Interest
5,523
3,774
1,570
Interest/NOPBT
11.98%
61.28%
20.17%